CIK 1689813

Biohaven Pharmaceutical Holding Company Ltd.

CIK 0001689813 · EDGAR ↗

cleanelevatedtriggeredno dataplanned

100.0

composite · 3 signals · TRIGGERED

Every card below shows the score and the exact filing data it was computed from — no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded — never a guess.

Chat with this filing →

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo — generate one →

Run the bounded investigation agent — reads this company's signals and writes a short, cited summary.

Signals

P-01 · FY 2021-12-31 · TRIGGERED100.0

Earnings quality

Beneish M-Score 2.63 exceeds the -1.78 manipulation threshold

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2022-02-25) ↗

Evidence — inputs and thresholds

{
  "m_score": 2.635,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 0.353,
    "GMI": 0.9,
    "AQI": 1.6,
    "SGI": 7.269,
    "DEPI": 0.799,
    "SGAI": 0.212,
    "LVGI": 1.358,
    "TATA": -0.014
  },
  "defaulted_to_neutral": [],
  "sloan_accruals": -0.0176,
  "inputs": {
    "revenue_t": 462509000,
    "revenue_t1": 63627000,
    "total_assets_t": 1077212000,
    "net_income_t": -846586000,
    "cfo_t": -831100000
  },
  "stale": false,
  "latest_filing_period": "2021-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1689813/000168981322000014/0001689813-22-000014-index.htm",
    "form": "10-K",
    "filed": "2022-02-25"
  }
}

P-12 · FY 2021-12-31 · TRIGGERED100.0

Restatement predictor

F-Score 3.31 — misstatement risk 3.3x the base rate

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2022-02-25) ↗

Evidence — inputs and thresholds

{
  "f_score": 3.308,
  "probability": 0.01224,
  "components": {
    "rsst": -0.0176,
    "drec": 0.2133,
    "dinv": 0.0465,
    "soft": 0.8267,
    "dcs": 3.3119,
    "droa": 0.3303,
    "issue": 1
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2021-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1689813/000168981322000014/0001689813-22-000014-index.htm",
    "form": "10-K",
    "filed": "2022-02-25"
  }
}

P-13 · FY 2018-12-31 · ELEVATED90.0

Zombie / distress

[FY2018 data, stale — no more recent EBIT figure in XBRL] Interest coverage -5909.32x below 1.0

trend: flat

Trend

Source: 10-K on SEC.gov (filed 2021-03-01) ↗

Evidence — inputs and thresholds

{
  "icr_by_year": {
    "2021-12-31": null,
    "2020-12-31": null,
    "2019-12-31": null,
    "2018-12-31": -5909.316
  },
  "consecutive_years_below_1": 1,
  "altman_z_double_prime": -3.332,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -224554000,
    "interest_expense_t": 38000
  },
  "stale": true,
  "latest_filing_period": "2021-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1689813/000168981321000024/0001689813-21-000024-index.htm",
    "form": "10-K",
    "filed": "2021-03-01"
  }
}